Related Experiment Video

Updated: May 2, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

16.3K

[Pharmacological prophylaxis and treatment of recidivating respiratory disorders in children]

M G Romantsov, I M Lysenko, I Iu Mel'nikova

    Eksperimental'Naia I Klinicheskaia Farmakologiia
    |March 22, 2014
    PubMed

    Insights

    Interferon inducers like cycloferon can prevent and treat acute respiratory diseases (ARDs) in children. Cycloferon

    Area of Science:

    • Immunology
    • Pediatrics
    • Pharmacology

    Background:

    • Interferon is a key mediator of natural immunity.
    • Acute Respiratory Diseases (ARDs) pose significant health challenges in children, particularly those who are sickly or experience recurrent infections.
    • Interferon inducers offer a potential therapeutic strategy for managing ARDs.

    Purpose of the Study:

    • To describe cycloferon, an endogenous interferon inducer.
    • To evaluate the prophylactic and therapeutic efficacy of cycloferon in children with recurrent ARDs.
    • To confirm the clinical and pharmacological effectiveness of cycloferon using proteomic analysis.

    Main Methods:

    • Describing the mechanism of action of cycloferon.
    • Clinical trials assessing prophylactic and therapeutic use in pediatric patients with recurrent ARDs.
    • Proteomic profiling of blood plasma in sickly children treated with cycloferon.

    Main Results:

    • Cycloferon demonstrated prophylactic and therapeutic efficacy in children suffering from recurrent ARDs.
    • The study confirmed the clinical and pharmacological effectiveness of cycloferon.
    • Proteomic analysis provided evidence supporting the drug's efficacy in sickly children.

    Conclusions:

    • Interferon inducers, specifically cycloferon, are effective agents for the treatment and prevention of ARDs in vulnerable pediatric populations.
    • Cycloferon shows promise as a therapeutic option for children with recurrent respiratory infections.
    • The findings support the use of cycloferon in pediatric practice for managing ARDs.

    More Related Videos

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    10.6K
    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    7.6K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    408
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    768
    Drugs Used in Lower Respiratory Disorders: Overview01:17

    Drugs Used in Lower Respiratory Disorders: Overview

    Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
    Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
    1.6K
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    4.2K
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    1.2K
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
    2.0K